New cancer injection seeks to boost radiation and immunotherapy power
Disease control
Recruiting now
This early-stage study is testing a new drug called RiMO-301, which is injected directly into tumors. It is being combined with a short, intense course of radiation and standard immunotherapy drugs (pembrolizumab or nivolumab) for people with advanced head and neck cancer that ca…
Phase: PHASE1, PHASE2 • Sponsor: Coordination Pharmaceuticals, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC